Changes to the global business regime as made by the Finance Act 2018 will be effective 1 July 2021.
Beginning 1 July 2021, a grandfathering period ends for deemed foreign tax credits, and partial exemptions will only be applicable with regard to certain specified income.
Companies that were issued a “Category 2 global business license” on or before 16 October 2017 will either have to convert to a “global business license company” or an authorised company by 30 June 2021. Other changes include new substance requirements, and satisfying the new substance requirements will be essential for a company to be eligible for the 80% partial tax exemption.
Read a September 2020 report [PDF 184 KB] prepared by the KPMG member firm in Mauritius
The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.